Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: Netherlands Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20072
20091
20111
20133
20142
20151
20162
20171
20181
20191
20201
20212
20223
20231
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting7
Recruiting4
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer3
Alexion Pharmaceuticals, Inc.2
Amgen2
Eli Lilly and Company2
GlaxoSmithKline2
UMC Utrecht2
A.C. Abrahams1
Astellas Pharma Europe B.V.1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic31
Anemia4
Heart Failure4
Hypertension4
Diabetes Mellitus, Type 23
Heart Diseases3
Kidney Diseases3
Kidney Failure, Chronic3
Proteinuria3
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.